Drug profile

The FDA adverse-event record for Electrolyte Solution

22 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Electrolyte Solution. See the species affected, top reactions, and outcomes below.

22
adverse-event reports
18.2%
death-coded share
Dog
most-reported species
8
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
22
Total Reports
4
Deaths Reported
18.2%
Death Rate

Active Ingredients

Electrolyte Solution

Administration Routes

UnknownIntravenousOralSubcutaneous

Species Affected

Dog 13
Cat 7
Pig 1
Ferret 1

Most Affected Breeds

Domestic Shorthair 3
Ragdoll 2
Rottweiler 2
Pig (unknown) 1
Pointing Dog - German Short-haired 1
Chihuahua 1
Shepherd Dog - Central Asian 1
Rex - Devon 1
Bulldog - English 1
Maine Coon 1

Most Reported Reactions

Vomiting 8
Decreased appetite 5
Other abnormal test result NOS 5
Lethargy (see also Central nervous system depression in Neurological) 5
Not eating 5
Hyperphosphataemia 4
Hypoglycaemia 4
Diarrhoea 4
Elevated total bilirubin 4
Elevated alanine aminotransferase (ALT) 4
Tachycardia 4
Death 3

Outcome Breakdown

Outcome Unknown
8 (34.8%)
Ongoing
7 (30.4%)
Recovered/Normal
4 (17.4%)
Died
3 (13.0%)
Euthanized
1 (4.3%)

Electrolyte Solution Adverse Event Insights

22 reports name Electrolyte Solution; 4 recorded a death outcome (18.2% of reported events, not a population-level mortality rate). Active ingredient: Electrolyte Solution. Administration routes: Unknown, Intravenous, Oral, Subcutaneous.

By species: Dog (13 reports), Cat (7 reports), Pig (1 reports). By breed: Domestic Shorthair (3), Ragdoll (2), Rottweiler (2).

Leading clinical signs: Vomiting (8), Decreased appetite (5), Other abnormal test result NOS (5), Lethargy (see also Central nervous system depression in Neurological) (5). Outcome, 23 coded reports: Outcome Unknown leads at 34.8%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.